Rituxan Hycela (rituximab and hyaluronidase)

**Product type:** Human Prescription Drug

**Active ingredient:** HYALURONIDASE (HUMAN RECOMBINANT); RITUXIMAB

**Strength:** 2000; 120 U/mL; mg/mL

**Dosage form:** Injection, Solution

**Route:** Subcutaneous

**Labeler:** Genentech, Inc.

**Marketing category:** BLA (BLA761064)

**Pharmacologic class:** CD20-directed Antibody Interactions [MoA], CD20-directed Cytolytic Antibody [EPC], Endoglycosidase [EPC], Glycoside Hydrolases [CS]